Optimal duration of oxaliplatin-based adjuvant chemotherapy in patients with different risk factors for stage II–III colon cancer: a meta-analysis

The 6-month FOLFOX regimen should only be recommended for high-risk stage III CC, while the 3-month regimen can be recommended for other stages. A 3-month CAPEOX regimen can be recommended for stage II-III CC.